277. Lymphangiomatosis
7 clinical trials,   2 drugs   (DrugBank: 2 drugs),   1 drug target gene,   50 drug target pathways

Searched query = "Lymphangiomatosis", "Generalized lymphatic anomaly", "Gorham disease", "Gorham-Stout disease", "Diffuse lymphangiomatosis", "Mass osteolysis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000014888
2014/06/0119/08/2014Everolimus for the treatment of lymphangiomatosis, Gorham-Stout disease and vascular anomalies Lymphangiomatosis, Gorham-Stout disease and vascular anomaliesOral everolimusGifu universityNULLComplete: follow-up completeNot applicable30years-oldMale and Female30Phase 1Japan